絞り込み

16403

広告

WERNER SYNDROME HELICASE HAS A CRITICAL ROLE IN DNA DAMAGE RESPONSES IN THE ABSENCE OF A FUNCTIONAL FANCONI ANEMIA PATHWAY.

著者 Aggarwal M , Banerjee T , Sommers JA , Iannascoli C , Pichierri P , Shoemaker RH , Brosh RM
Cancer Res.2013 Jul 18 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

Laboratory of Molecular Gerontology, National Institute on Aging, NIH.

スターを付ける スターを付ける     (109view , 0users)

Full Text Sources

Medical

Miscellaneous

Werner syndrome (WS) is genetically linked to mutations in WRN that encodes a DNA helicase-nuclease believed to operate at stalled replication forks. Using a newly identified small molecule inhibitor of WRN helicase (NSC 617145), we investigated the role of WRN in the interstrand cross-link (ICL) response in cells derived from patients with Fanconi Anemia (FA), a hereditary disorder characterized by bone marrow failure and cancer. In FA-D2-/- cells, NSC 617145 acted synergistically with very low concentrations of Mitomycin C (MMC) to inhibit proliferation in a WRN-dependent manner, and induce double strand breaks (DSBs) and chromosomal abnormalities. Under these conditions, ATM activation and accumulation of DNA-PKcs pS2056 foci suggested an increased number of DSBs processed by nonhomologous end-joining (NHEJ). Rad51 foci were also elevated in FA-D2-/- cells exposed to NSC 617145 and MMC, suggesting that WRN helicase inhibition interferes with later steps of homologous recombination (HR) at ICL-induced DSBs. Thus, when the FA pathway is defective, WRN helicase inhibition perturbs the normal ICL response, leading to NHEJ activation. Potential implication for treatment of FA-deficient tumors by their sensitization to DNA cross-linking agents is discussed.
PMID: 23867477 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード